Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents.

Recently, selective and systemically active antagonists for the metabotropic glutamate 5 receptor (mGlu(5)) were discovered, and the most potent derivative was found to be MPEP (2-methyl-6-(phenylethynyl)pyridine). Given the high expression of mGlu(5) receptors in limbic forebrain regions, it was decided to evaluate the anxiolytic potential of MPEP. After an acute oral administration, MPEP attenuated the anxiety-dependent variable in a variety of well established anxiety test paradigms. In rats, MPEP (10, 30, and 100 mg/kg) increased punished responses in the Geller-Seifter test, but none of these effects reached statistical significance. MPEP significantly increased the ratio (open/total arm entries; 0.1, 1, and 10 mg/kg), the number of open arm entries (0.1, 1, and 10 mg/kg), as well as time spent on open arm (0.1 and 1 mg/kg) in the elevated plus maze test. Furthermore, MPEP (0.3 and 1 mg/kg) significantly increased the time spent in social contact in the social exploration test. In mice, MPEP attenuated stress-induced hyperthermia (15 and 30 mg/kg) and decreased the number of buried marbles in the marble burying test (7.5 and 30 mg/kg). Finally, MPEP (0.01, 0.1, 1, 10, and 100 mg/kg) was tested on spontaneous locomotor activity in mice, and only a dose of 100 mg/kg significantly reduced vertical activity; no effect was seen on horizontal activity. MPEP (7.5, 15, and 30 mg/kg) was ineffective on d-amphetamine-induced (2.5 mg/kg) locomotor activity in mice and prepulse inhibition in rats (1, 3, or 10 mg/kg). Thus, these findings indicate that MPEP exhibits anxiolytic-like effects and low risks for sedation and psychotomimetic side-effects in rodents.

• Publication year

  2000

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2000-12-01

• Fields of study

  Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.1016/s0022-3565(24)39029-9PMID 11082464
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological validation of a novel animal model of anticipatory anxiety in mice

  2005cited by this paper
• mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia.

  2001cited by this paper
• Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain.

  2001cited by this paper
• 5-HT(3) receptor antagonists and anxiety; a preclinical and clinical review.

  2000cited by this paper
• Effects of the prototypical mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats.

  2000cited by this paper
• 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist.

  1999cited by this paper
• SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5.

  1999cited by this paper
• F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.

  1998cited by this paper
• Glutamate in CNS disorders as a target for drug development: an update.

  1998cited by this paper
• Pharmacology and functions of metabotropic glutamate receptors.

  1997cited by this paper
• Anxiety, defence and the elevated plus-maze.

  1997cited by this paper
• Animal models of 'anxiety': where next?

  1997cited by this paper
• Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety.

  1996cited by this paper
• Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?

  1996cited by this paper
• Basal ganglia and movement disorders: an update.

  1996cited by this paper
• The metabotropic glutamate receptors: structure and functions.

  1995cited by this paper
• Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain

  1995cited by this paper
• Metabotropic glutamate receptors: novel targets for drug development.

  1995cited by this paper
• Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat

  1994cited by this paper
• Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain.

  1993cited by this paper
• The functional anatomy of basal ganglia disorders.

  1989cited by this paper
• The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system.

  1989cited by this paper
• Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice.

  1986cited by this paper
• Endogenous hyperthermia in normal human subjects: experimental study of emotional states (II).

  1985cited by this paper
• Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ‘fear’-motivated behaviour

  1984cited by this paper
• Molecular Neurobiology of the Mammalian Brain

  1978cited by this paper
• Effects of combined treatment with trifluoperazine-HCl and amobarbital on punished behavior in rats

  1969cited by this paper

• mGluR5 as a Potential Orchestrator of Astrocyte Interactions in Neurological Disorders

  2025cites this paper
• Quantification of [11C]ABP688 Binding to mGluR5 in Human Brain using Cerebellum as Reference Region: Biological Interpretation and Limitations

  2025cites this paper
• Motor behavior induced by bergamot essential oil in experimental tasks is differentially modulated by pretreatment with metabotropic glutamate receptor 2/3 or 5 antagonists

  2024cites this paper
• Loss of mGlu5 receptors in somatostatin-expressing neurons alters negative emotional states

  2024cites this paper
• mGluR5 in hippocampal CA1 pyramidal neurons mediates stress-induced anxiety-like behavior

  2023cites this paper
• Control of Theta Oscillatory Activity Underlying Fear Expression by mGlu5 Receptors

  2022cites this paper
• Genetic disruption of Grm5 causes complex alterations in motor activity, anxiety and social behaviors.

  2021influential citation
• Auditory Hypersensitivity and Processing Deficits in a Rat Model of Fragile X Syndrome

  2021cites this paper
• Negative Modulation of the Metabotropic Glutamate Receptor Type 5 as a Potential Therapeutic Strategy in Obesity and Binge-Like Eating Behavior

  2021cites this paper
• Synthesis, Biodistribution, and Radiation Dosimetry of a Novel mGluR5 Radioligand: 18F-AZD9272

  2020cites this paper
• The bivalent ligand, MMG22, reduces neuropathic pain after nerve injury without the side effects of traditional opioids.

  2020cites this paper
• Current Radioligands for the PET Imaging of Metabotropic Glutamate Receptors

  2020cites this paper
• Simultaneous PET-MR-EEG: Technology, Challenges and Application in Clinical Neuroscience

  2019cites this paper
• mGluR5 and Stress Disorders: Knowledge Gained from Receptor Imaging Studies

  2019cites this paper
• Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology

  2019cites this paper
• The Role of Metabotropic Glutamate Receptors in Social Behavior in Rodents

  2019cites this paper
• Drugs to Tune Up Glutamatergic Systems: Modulators of Glutamate Metabotropic Receptors

  2018cites this paper
• Differential activation of arginine-vasopressin receptor subtypes in the amygdaloid modulation of anxiety in the rat by arginine-vasopressin

  2018cites this paper
• A first-in-man PET study of [18F]PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5

  2018cites this paper
• Targeting mGlu5 Metabotropic Glutamate Receptors in the Treatment of Cognitive Dysfunction in a Mouse Model of Phenylketonuria

  2018cites this paper
• Chapter 71 – Negative Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5 for the Treatment of Cocaine Use Disorder

  2017cites this paper
• Metabotropic Glutamate Receptors – Regulation of Acute and Chronic Stress-Related Behavior and Physiology

  2017influential citation
• Anxiolytic effect of fatty acids and terpenes fraction from Aloysia triphylla: Serotoninergic, GABAergic and glutamatergic implications.

  2017cites this paper
• Discovery and Characterization of (R)-6-Neopentyl-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-one (PF-06462894), an Alkyne-Lacking Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator Profiled in both Rat and Nonhuman Primates.

  2017cites this paper
• Chronic oral administration of MPEP, an antagonist of mGlu5 receptor, during gestation and lactation alters mGlu5 and A2A receptors in maternal and neonatal brain.

  2017cites this paper
• Metabotropic Glutamatergic Receptor 5 and Stress Disorders: Knowledge Gained From Receptor Imaging Studies.

  2017cites this paper
• Social Isolation During Adolescence Induces Anxiety Behaviors and Enhances Firing Activity in BLA Pyramidal Neurons via mGluR5 Upregulation

  2017cites this paper
• Metabotropic Glutamate Receptors in Amygdala Functions

  2017cites this paper
• Biological Basis of Behavior Program 10-7-2011 mGluR 5-Antagonist Mediated Reversal of Elevated Stereotyped , Repetitive Behaviors in the VPA Model of Autism

  2017cites this paper
• Inhibition of group-I metabotropic glutamate receptors protects against prion toxicity

  2017cites this paper
• N-Alkylpyrido[1',2':1,5]pyrazolo-[4,3-d]pyrimidin-4-amines: A new series of negative allosteric modulators of mGlu1/5 with CNS exposure in rodents.

  2016cites this paper
• Metabotropic Glutamate Receptors in Central Nervous System Diseases.

  2016cites this paper
• 4-Aryl-3-arylsulfonyl-quinolines as negative allosteric modulators of metabotropic GluR5 receptors: From HTS hit to development candidate.

  2016cites this paper
• 2-Methyl-6-(phenylethynyl)pyridine Hydrochloride Modulates Metabotropic Glutamate 5 Receptors Endogenously Expressed in Zebrafish Brain.

  2016cites this paper
• A review of animal models of obsessive-compulsive disorder: a focus on developmental, immune, endocrine and behavioral models

  2016cites this paper
• Molecular mechanisms of group I metabotropic glutamate receptor mediated LTP and LTD in basolateral amygdala in vitro

  2016cites this paper
• Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias

  2016cites this paper
• The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders

  2016cites this paper
• VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy

  2016influential citation
• Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile).

  2015cites this paper
• Effects on Behavior and Muscle Coordination

  2015cites this paper
• Identification of alpha-substituted acylamines as novel, potent, and orally active mGluR5 negative allosteric modulators.

  2015cites this paper
• Blockade of mGluR5 in the nucleus accumbens shell but not core attenuates heroin seeking behavior in rats

  2014cites this paper
• 2-Methyl-6-(phenylethynyl) pyridine (MPEP) reverses maze learning and PSD-95 deficits in Fmr1 knock-out mice

  2014cites this paper
• Metabotropic glutamatergic receptors and their ligands in drug addiction.

  2014cites this paper
• AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: identification, SAR and pharmacological characterization.

  2014cites this paper
• Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications.

  2014cites this paper
• Metabotropic glutamate receptor 5 binding in patients with obsessive-compulsive disorder.

  2014cites this paper
• Discovery of VU0431316: a negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety.

  2014cites this paper
• Influence of stimulant-induced hyperactivity on social approach in the BTBR mouse model of autism.

  2013cites this paper
• mGlu5 negative allosteric modulators: a patent review (2013 - 2016)

  2013cites this paper
• Glutamate-based anxiolytic ligands in clinical trials

  2013cites this paper
• Substituted oxadiazoles: a patent review (2010 – 2012)

  2013cites this paper
• Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression.

  2013cites this paper
• Significant increase in anxiety during aging in mGlu5 receptor knockout mice.

  2013cites this paper
• Palladium mediated ¹¹C-cyanation and characterization in the non-human primate brain of the novel mGluR5 radioligand [¹¹C]AZD9272.

  2013cites this paper
• A positron emission tomography study in healthy volunteers to estimate mGluR5 receptor occupancy of AZD2066 - Estimating occupancy in the absence of a reference region

  2013cites this paper
• Interaction between the mGlu receptors 5 antagonist, MPEP, and amphetamine on memory and motor functions in mice

  2013cites this paper
• mGlu5 negative allosteric modulators: a patent review (2010 – 2012)

  2013cites this paper
• Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety.

  2013cites this paper
• Discovery of (1R,2R)-N-(4-(6-isopropylpyridin-2-yl)-3-(2-methyl-2H-indazol-5-yl)isothiazol-5-yl)-2-methylcyclopropanecarboxamide, a potent and orally efficacious mGlu5 receptor negative allosteric modulator.

  2013cites this paper
• Pharmacology of metabotropic glutamate receptor allosteric modulators: structural basis and therapeutic potential for CNS disorders.

  2013cites this paper
• Effects of MPEP, a selective metabotropic glutamate mGlu5 ligand, on sleep and wakefulness in the rat.

  2013cites this paper
• Synthesis and biological evaluation of 2-(arylethynyl)quinoline derivatives as mGluR5 antagonists for the treatment of neuropathic pain.

  2013cites this paper
• Novel roles for the GABAB receptor in anxiety and cocaine addiction

  2013influential citation
• Regulation of N-Methyl-d-aspartic Acid (NMDA) Receptors by Metabotropic Glutamate Receptor 7*♦

  2012cites this paper
• (–)‐2‐oxa‐4‐aminobicylco[3.1.0]hexane‐4,6‐dicarboxylic acid (LY379268) and 3‐[(2‐methyl‐1,3‐thiazol‐4‐yl)ethynyl]piperidine (MTEP) similarly attenuate stress‐induced reinstatement of cocaine seeking

  2012cites this paper
• Therapeutic Potential of Metabotropic Glutamate Receptor Modulators

  2012cites this paper
• Differential effects of diazepam and MPEP on habituation and neuro-behavioural processes in inbred mice

  2012cites this paper
• New perspectives in glutamate and anxiety.

  2012influential citation
• Metabotropic and ionotropic glutamate receptors as neurobiological targets in anxiety and stress-related disorders: focus on pharmacology and preclinical translational models.

  2012cites this paper
• Discovery and characterization of AZD9272 and AZD6538-Two novel mGluR5 negative allosteric modulators selected for clinical development.

  2012cites this paper
• Discovery of 2‐(2‐Benzoxazoyl amino)‐4‐Aryl‐5‐Cyanopyrimidine as Negative Allosteric Modulators (NAMs) of Metabotropic Glutamate Receptor 5 (mGlu5): From an Artificial Neural Network Virtual Screen to an In Vivo Tool Compound

  2012cites this paper
• The mGlu5 receptor antagonist MPEP activates specific stress-related brain regions and lacks neurotoxic effects of the NMDA receptor antagonist MK-801: significance for the use as anxiolytic/antidepressant drug.

  2012influential citation
• Metabotropic glutamate receptor 5 negative allosteric modulators as novel tools for in vivo investigation.

  2012cites this paper
• Catalysis by zeolite leading to the construction of thiazole ring: an improved synthesis of 4-alkynyl substituted thiazoles

  2012cites this paper
• Activation of amygdalar metabotropic glutamate receptors modulates anxiety, and risk assessment behaviors in ovariectomized estradiol-treated female rats.

  2012cites this paper
• Recent disclosures of clinical candidates - Highlights from the Society for Medicines Research Symposium, held on December 8, 2011 at The National Heart and Lung Institute, South Kensington, London, UK

  2012cites this paper
• Recent advances in the design and development of novel negative allosteric modulators of mGlu(5).

  2011cites this paper
• Metabotropic glutamate receptors: from the workbench to the bedside.

  2011cites this paper
• Metabotropic Glutamate Receptors in Peripheral Tissues: Implications for Toxicology

  2011cites this paper
• Advances in the treatment of anxiety: Targeting glutamate

  2011cites this paper
• mGluR5-Antagonist Mediated Reversal of Elevated Stereotyped, Repetitive Behaviors in the VPA Model of Autism

  2011cites this paper
• FMRP dependent synaptic delivery of messenger RNA

  2011cites this paper
• Investigations into the role of the metabotropic glutamate receptor, mGluR5, in incentive learning and some behavioural and neurobiological effects of cocaine

  2011cites this paper
• (3-Cyano-5-fluorophenyl)biaryl negative allosteric modulators of mGlu(5): Discovery of a new tool compound with activity in the OSS mouse model of addiction.

  2011cites this paper
• Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential.

  2011cites this paper
• The age of anxiety: role of animal models of anxiolytic action in drug discovery

  2011cites this paper
• EFFECTS OF RETAMA RAETAM (FORSSK.) WEBB & BERTHEL. (FABACEAE) ON THE CENTRAL NERVOUS SYSTEM IN EXPERIMENTAL ANIMALS

  2011cites this paper
• Lifelong CRF overproduction is associated with altered gene expression and sensitivity of discrete GABAA and mGlu receptor subtypes

  2011influential citation
• Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome.

  2011cites this paper
• Selective Interactions of Valeriana officinalis Extracts and Valerenic Acid with [3H]Glutamate Binding to Rat Synaptic Membranes

  2011cites this paper
• Neural circuitry and neuroplasticity in mood disorders: Insights for novel therapeutic targets

  2011cites this paper
• Selective mGluR5 antagonism attenuates the stress-induced reduction of MK-801's antiseizure potency in the genetically inbred Balb/c mouse.

  2011cites this paper
• Group I metabotropic glutamate receptor antagonists alter select behaviors in a mouse model for fragile X syndrome

  2011cites this paper
• Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist produces anxiolytic-like effects and reverses abnormal firing activity of projection neurons in the basolateral nucleus of the amygdala in rats with bilateral 6-OHDA lesions.

  2011cites this paper
• Aqueous and Ethanolic Valeriana officinalis Extracts Change the Binding of Ligands to Glutamate Receptors

  2010cites this paper
• Hit-to-lead optimization of disubstituted oxadiazoles and tetrazoles as mGluR5 NAMs.

  2010cites this paper
• Metabotropic glutamate receptor subtype 5 antagonism in learning and memory.

  2010cites this paper
• [The role of the glutamatergic system in the pathogenesis and treatment of alcohol dependence].

  2010cites this paper